154 companies

Curaleaf Holdings

Market Cap: CA$2.8b

Produces and distributes cannabis products in the United States and internationally.

CURA

CA$3.58

7D

1.7%

1Y

55.0%

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$11.10

7D

2.8%

1Y

-4.6%

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

TRUL

CA$11.91

7D

13.2%

1Y

56.7%

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

CRON

CA$3.69

7D

1.4%

1Y

27.7%

Bright Minds Biosciences

Market Cap: CA$901.8m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

DRUG

CA$115.80

7D

4.6%

1Y

98.6%

Vireo Growth

Market Cap: CA$875.2m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

VREO

CA$0.82

7D

-6.8%

1Y

-3.5%

Cresco Labs

Market Cap: CA$777.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

CL

CA$1.74

7D

8.8%

1Y

23.4%

Verano Holdings

Market Cap: CA$657.5m

Operates as a vertically integrated multi-state cannabis operator in the United States.

VRNO

CA$1.81

7D

9.0%

1Y

-5.7%

NervGen Pharma

Market Cap: CA$628.2m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

NGEN

CA$7.93

7D

13.3%

1Y

156.6%

Knight Therapeutics

Market Cap: CA$586.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

GUD

CA$5.91

7D

-1.5%

1Y

9.0%

Canopy Growth

Market Cap: CA$561.2m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

WEED

CA$1.64

7D

-0.6%

1Y

-61.0%

Eupraxia Pharmaceuticals

Market Cap: CA$529.8m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

EPRX

CA$10.46

7D

-1.6%

1Y

146.7%

Spectral Medical

Market Cap: CA$399.0m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

EDT

CA$1.38

7D

6.2%

1Y

142.1%

TerrAscend

Market Cap: CA$386.1m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

TSND

CA$1.05

7D

8.2%

1Y

8.2%

Cipher Pharmaceuticals

Market Cap: CA$378.1m

Operates as a specialty pharmaceutical company in Canada.

CPH

CA$14.90

7D

-0.5%

1Y

1.8%

Aurora Cannabis

Market Cap: CA$336.8m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB

CA$5.94

7D

0.7%

1Y

-10.8%

High Tide

Market Cap: CA$334.5m

Engages in the cannabis retail business in Canada.

HITI

CA$3.84

7D

3.8%

1Y

-19.3%

Organigram Global

Market Cap: CA$320.0m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

OGI

CA$2.37

7D

2.2%

1Y

-1.7%

Auxly Cannabis Group

Market Cap: CA$195.5m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

XLY

CA$0.14

7D

3.6%

1Y

190.0%

Helix BioPharma

Market Cap: CA$183.3m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

HBP

CA$2.40

7D

0%

1Y

158.1%

Grown Rogue International

Market Cap: CA$174.8m

A craft cannabis company, focuses on premium flower and flower-derived products.

GRIN

CA$0.70

7D

7.7%

1Y

-24.7%

HLS Therapeutics

Market Cap: CA$151.7m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

HLS

CA$4.85

7D

1.9%

1Y

24.7%

BioSyent

Market Cap: CA$143.7m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

RX

CA$12.76

7D

-1.1%

1Y

14.1%

Cardiol Therapeutics

Market Cap: CA$134.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

CRDL

CA$1.36

7D

2.3%

1Y

-31.7%

Satellos Bioscience

Market Cap: CA$129.9m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

MSCL

CA$0.70

7D

4.5%

1Y

-19.5%

ME Therapeutics Holdings

Market Cap: CA$120.2m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

METX

CA$4.00

7D

0%

1Y

0%

Atlas Energy

Market Cap: CA$110.2m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

ATLE

CA$0.17

7D

12.9%

1Y

-53.3%

Medexus Pharmaceuticals

Market Cap: CA$100.3m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$3.09

7D

4.0%

1Y

-11.0%

Planet 13 Holdings

Market Cap: CA$89.5m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

PLTH

CA$0.28

7D

-1.8%

1Y

-50.0%

Charlotte's Web Holdings

Market Cap: CA$89.3m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

CWEB

CA$0.56

7D

0%

1Y

229.4%

Medicenna Therapeutics

Market Cap: CA$83.4m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

MDNA

CA$1.00

7D

6.4%

1Y

-33.3%

BioNxt Solutions

Market Cap: CA$79.6m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

BNXT

CA$0.65

7D

3.2%

1Y

51.2%

Onco-Innovations

Market Cap: CA$78.6m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

ONCO

CA$1.40

7D

3.7%

1Y

45.8%

MTL Cannabis

Market Cap: CA$75.8m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

MTLC

CA$0.63

7D

-4.5%

1Y

37.0%

C21 Investments

Market Cap: CA$63.7m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

CXXI

CA$0.54

7D

11.3%

1Y

107.7%

Vext Science

Market Cap: CA$61.5m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

VEXT

CA$0.24

7D

-7.5%

1Y

44.1%

Page 1 of 5